FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fernando de Alvaro

Research Profile

Procedures

Disorders

Geographic Areas

Spain

Anatomy

Peritoneum

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
José Portolés; Esther Rubio; Vicente Alvarez-Chivas; Pedro Aranda; Fernando de Alvaro; Florencio García; Jose Luis Gorriz; Alberto Martinez-Castelao
The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease.
Alberto Martínez-Castelao; Rafael Montes; Aparna Natarajan; Juan F Navarro-González; José Portolés; Aleix Cases; Fernando de Alvaro; Juan J de la Cruz-Troca; José Luis Górriz; José Luño; Daniel Batlle
Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study.
J M Lobos; M A Royo-Bordonada; C Brotons; L Alvarez-Sala; P Armario; A Maiques; Dídac Mauricio; Susana Sans; F Villar; A Lizcano; A Gil-Núñez; Fernando de Alvaro; Pedro Conthe; E Luengo; A del Río; O Rico; A de Santiago; M A Vargas; M Martíonez; V Lizarbe
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Spanish adaptation of the CEIPC 2008].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fernando de Alvaro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: José Portolés; Esther Rubio; Vicente Alvarez-Chivas; Pedro Aranda; Fernando de Alvaro; Florencio García; Jose Luis Gorriz; Alberto Martinez-Castelao
The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease.
BMC nephrology 2013;14():2.
2011: Alberto Martínez-Castelao; Rafael Montes; Aparna Natarajan; Juan F Navarro-González; José Portolés; Aleix Cases; Fernando de Alvaro; Juan J de la Cruz-Troca; José Luis Górriz; José Luño; Daniel Batlle
Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study.
BMC nephrology 2011;12():53.
2009: J M Lobos; M A Royo-Bordonada; C Brotons; L Alvarez-Sala; P Armario; A Maiques; Dídac Mauricio; Susana Sans; F Villar; A Lizcano; A Gil-Núñez; Fernando de Alvaro; Pedro Conthe; E Luengo; A del Río; O Rico; A de Santiago; M A Vargas; M Martíonez; V Lizarbe
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Spanish adaptation of the CEIPC 2008].
Neurología (Barcelona, Spain) 2009;24(7):465-84.
2009: José M A Lobos Bejarano; Miguel Angel Royo-Bordonada; Carlos Brotons; Luís Alvarez-Sala; Pedro Armario; Antonio Maiques; Dídac Mauricio; Susana Sans; Fernando Villar; Angel Lizcano; Antonio Gil-Núñez; Fernando de Alvaro; Pedro Conthe; Emilio Luengo; Alfonso Del Río; Olga Cortés; Ana de Santiago; Miguel A Vargas; Mercedes Martínez; Vicenta Lizarbe
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish Adaptation].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2009;41(8):463.e1-463.e24.
2009: J M Lobos; Miguel Angel Royo-Bordonada; C Brotons; L Alvarez-Sala; P Armario; A Maiques; Dídac Mauricio; S Sans; F Villar; A Lizcano; A Gil-Núñez; Fernando de Alvaro; Pedro Conthe; E Luengo; A Del Río; O Cortés; A de Santiago; M A Varga; M Martínez; V Lizarbe
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish adaptation].
Revista clínica española 2009;209(6):279-302.
2009: José R Banegas; Albert Jovell; Benjamín Abarca; Manuel Aguilar-Diosdado; Luis Aguilera; Pedro Aranda; Vicente Bertoméu; Pedro Capilla; Pedro Conthe; Fernando de Alvaro; Antonio Fernández-Pro; Xavier Formiguera; Jesús Frías; Lucía Guerrero; José L Llisterri; José M Lobos; Juan F Macías; Angel L Martín de Francisco; Jesús Millán; Juan C Morales; Vicente Palomo; Alex Roca-Cusachs; Javier Román; Carlos Sanchis; Antonio Sarriá; Julián Segura; Alex De La Sierra; Luis Verde; Julio Zarco; Luis M Ruilope
[Hypertension and health policy in Spain].
Medicina clínica 2009;132(6):222-9.
2009: José Portolés; Alberto Martinez Castelao; Jose Luis Gorriz; Ana Maria Tato; Fernando de Alvaro
Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease.
Renal failure 2009;31(10):869-75.
2008: Iain C Macdougall; Rowan Walker; Robert Provenzano; Fernando de Alvaro; Harold R Locay; Paul C Nader; Francesco Locatelli; Frank C Dougherty; Ulrich Beyer
C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(2):337-47.
2007: Olga Costero; Fernando de Alvaro; Ignacio Bernardino; Rafael Selgas
[Pseudopheochromocytoma as cause of severe and paroxysmal hypertension].
Medicina clínica 2007;129(9):358-9.
2007: Eberhard Ritz; Maurice Laville; Rudy Bilous; Donal O'Donoghue; Armin Scherhag; Ulrich Burger; Fernando de Alvaro
Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(2):194-207.
2006: Fernando de Alvaro; Miguel Angel Hernández-Presa
Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
Journal of cardiovascular pharmacology 2006;47(2):271-6.
2006: Roberto Alcazar; Olga Gonzalez Albarran; Jesús Honorato; Nicolás Roberto Robles; Javier Acha; Fernando de Alvaro; Victor Fernandez Gallego; Pablo Gomez Garcia; Martin Lopez de la Torre; Alberto Martinez-Castelao; Ramon Romero
[Practical management of oral antidiabetics in patients with renal disease].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2006;26(5):538-58.
2006: Luis Cea-Calvo; Pedro Conthe; Pablo Gómez-Fernández; Fernando de Alvaro; Cristina Fernández-Pérez
Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.
Cardiovascular diabetology 2006;5():23.
2005: Alberto Martínez-Castelao; Fernando de Alvaro; José Luis Górriz
Epidemiology of diabetic nephropathy in Spain.
Kidney international. Supplement 2005;(99):S20-4.
2005: Marc A Pohl; Samuel Blumenthal; Daniel J Cordonnier; Fernando de Alvaro; Giacomo Deferrari; Gilbert Eisner; Enric Esmatjes; Richard E Gilbert; Lawrence G Hunsicker; José B Lopes De Faria; Ruggero Mangili; Jack Moore; Efrain Reisin; Eberhard Ritz; Guntram Schernthaner; Samuel Spitalewitz; Hilary Tindall; Roger A Rodby; Edmund J Lewis
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.
Journal of the American Society of Nephrology : JASN 2005;16(10):3027-37.
2005: Fernando de Alvaro; Alberto Martínez-Castelao; José Luis Górriz
[Importance of early determination of microalbuminuria in global vascular risk and diabetic nephropathy].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2005;25 Suppl 4():34-41.
2005: Alberto Martínez-Castelao; Fernando de Alvaro; José Luis Górriz; M T González
[Consensus guidelines for managing diabetic nephropathy: are they really valid?].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2005;25 Suppl 4():28-33.
2005: Andrew J Palmer; Lieven Annemans; Stéphane Roze; Pablo Lapuerta; Roland Chen; Sylvie Gabriel; Paulo Carita; Roger A Rodby; Dick de Zeeuw; Hans-Henrik Parving; Fernando de Alvaro
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria.
Kidney international. Supplement 2005;(93):S52-4.
2005: Fernando de Alvaro; Olga Velasco; Jesús Honorato; Carlos Calvo; Inma Parrondo
Microalbuminuria in hypertensive patients: evaluation of one-year treatment with irbesartan.
Kidney international. Supplement 2005;(93):S29-34.
2004: Carlos Brotons; Miguel Angel Royo-Bordonada; Luís Alvarez-Sala; Pedro Armario; Rosario Artigao; Pedro Conthe; Fernando de Alvaro; Ana de Santiago; A Gil; José Maria Lobos; Antonio Maiques; J Marrugat; Dídac Mauricio; F Rodríguez-Artalejo; Susana Sans; C Suárez
[Spanish adaptation of the European Guide to Cardiovascular Prevention (I)].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2004;34(8):427-32.
2004: Carlos Brotons; Miguel Angel Royo-Bordonada; Luís Alvarez-Sala; Pedro Armario; Rosario Artigao; Pedro Conthe; Fernando de Alvaro; Ana de Santiago; A Gil; José Maria Lobos; Antonio Maiques; J Marrugat; Dídac Mauricio; F Rodriguez-Artalejo; Susana Sans; C Suarez
[Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention].
Neurología (Barcelona, Spain) 2004;19(8):438-9.
2004: Fernando de Alvaro
When to start dialysis in diabetic patients?
EDTNA/ERCA journal (English ed.) 2004;30(3):143-7.
2004: Carlos Brotons; Miguel Angel Royo-Bordonada; Luís Alvarez-Sala; Pedro Armario; Rosario Artigao; Pedro Conthe; Fernando de Alvaro; Ana de Santiago; Antonio Gil; José Maria Lobos; Antonio Maiques; Jaume Marrugat; Dídac Mauricio; Fernando Rodríguez Artalejo; Susana Sans; Carmen Suárez
[Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention].
Revista española de salud pública 2004;78(4):435-8.
2004: Alberto Martínez-Castelao; José Luis Gòrriz; Fernando Garcia-López; Katia López Revuelta; Fernando de Alvaro; Josep M Cruzado
Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
Journal of nephrology 2004;17(4):544-51.
2004: Cándido Díaz; Fernando Gil Catalinas; Fernando de Alvaro; Alberto Torre; Carmen Sánchez; Olga Costero
Long daily hemodialysis sessions correct systemic complications of oxalosis prior to combined liver-kidney transplantation: case report.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(1):52-5.
2004: Silvia Ros; Jorge Martínez-Ara; M A García de Miguel; Teresa Olea; Fernando de Alvaro
[Familial Henoch-Schönlein purpura manifested with lung hemorrhage].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2004;24(5):499-502.
2004: Andrew J Palmer; Lieven Annemans; Stéphane Roze; Mark Lamotte; Roger A Rodby; Fernando de Alvaro
[Cost-efectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2004;24(3):231-8.
2002: Enric Esmatjes; Fernando de Alvaro
Incidence of diabetic nephropathy in Type 1 diabetic patients in Spain: 'Estudio Diamante'.
Diabetes research and clinical practice 2002;57(1):35-43.
2002: C Díaz Rodríguez; Olga Costero; Alberto Torre; Fernando de Alvaro; Fernando Gil; María L Picazo; Jorge Martínez-Ara
[Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2002;22(2):190-5.
2001: Olga Costero; Cándido Díaz; Fernando de Alvaro; Alberto Torre; Fernando Gil; María L Picazo; Jorge Martínez-Ara
[Idiopathic membranous nephropathy in an elderly patient with type 2 diabetes mellitus].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2001;21(4):402-5.
2001: Alberto Martínez-Castelao; Fernando de Alvaro; José Luis Górriz
[Treatment of the diabetic patient with kidney failure].
Nefrología : publicación oficial de la Sociedad Española Nefrologia 2001;21 Suppl 3():66-75.
1997: M Auxiliadora Bajo; Rafael Selgas; M José Castro; Carlos Jiménez; María J Fernández-Reyes; Gloria del Peso; Fernando de Alvaro; A L Sanchez-Sicilia
Erythropoietin treatment decreases cardiovascular morbidity and mortality in CAPD patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1997;17(2):129-35.
1997: M Auxiliadora Bajo; Rafael Selgas; C Possante; Abelardo Aguilera; C Sánchez; C Diaz; Fernando de Alvaro; M E Martinez
Frequent recurrence of secondary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1997;13():239-43.
1997: Juan J Díez; Pedro Iglesias; M Auxiliadora Bajo; Fernando de Alvaro; Rafael Selgas
Effects of erythropoietin on gonadotropin responses to gonadotropin-releasing hormone in uremic patients.
Nephron 1997;77(2):169-75.
1997: MA Martínez Olmos; L Herranz de la Morena; Pilar Martín Vaquero; A Marco Martínez; Cristina Grande; Fernando de Alvaro; F Dapena; Luis Felipe Pallardo
[The metabolic control of insulin-dependent diabetes mellitus and diabetic nephropathy].
Revista clínica española 1997;197(1):18-22.
1996: M A Castro; M Fernandez de Castro; Rafael Selgas; M J Fernandez-Reyes; M Auxiliadora Bajo; C Jimenez; Gloria del Peso; F Dapena; Fernando de Alvaro
Circulating burst-forming unit-erythroid (BFU-E) colonies as an early marker to measure the recombinant human erythropoietin response in peritoneal dialysis patients.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1996;12():66-70.
1996: Rafael Selgas; M Auxiliadora Bajo; M J Fernandez-Reyes; C Jimenez; Gloria del Peso; C Sanchez; Fernando de Alvaro
Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1996;12():49-52.
1996: Rafael Selgas; M Auxiliadora Bajo; C Jimenez; C Sanchez; Gloria del Peso; G Cacho; C Diaz; M J Fernandez-Reyes; Fernando de Alvaro
Peritoneal dialysis in liver disorders.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1996;16 Suppl 1():S215-9.
1995: M J Fernandez-Reyes; Rafael Selgas; M Auxiliadora Bajo; C Jimenez; Gloria del Peso; M C Sanchez; F Dapena; Fernando de Alvaro
Increased response to subcutaneous erythropoietin on type I diabetic patients on CAPD: is there a synergistic effect with insulin?
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1995;15(6):231-5.
1994: Rafael Selgas; M J Fernandez-Reyes; E Bosque; M Auxiliadora Bajo; F Borrego; C Jimenez; Gloria del Peso; Fernando de Alvaro
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1994;23(1):64-73.
1994: M Auxiliadora Bajo; Rafael Selgas; C Jimenez; Gloria del Peso; M J Fernandez-Reyes; F Dapena; Fernando de Alvaro
CAPD for treatment of ESRD patients with ascites secondary to liver cirrhosis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1994;10():73-6.
1994: Fernando de Alvaro; Rafael Selgas; M Auxiliadora Bajo; P Serrano; María J Fernández-Reyes; Gloria del Peso; C Jimenez; G Garcia; F Dapena
Moncrief's technique for peritoneal catheter placement: experience of a CAPD unit.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1994;10():199-202.
1994: M Fernandez de Castro; Rafael Selgas; C Jimenez; M Auxiliadora Bajo; V Martinez; J R Romero; Fernando de Alvaro; F Vara
Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1994;14(3):265-70.
1994: F Dapena; Rafael Selgas; A Garcia-Perea; Gloria del Peso; M Auxiliadora Bajo; M J Fernandez Reyes; C Jimenez; C Sánchez; I Muñoz; Fernando de Alvaro
Clinical significance of exit-site infections due to Xanthomonas in CAPD patients: a comparison with Pseudomonas infection.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(12):1774-7.
1993: Rafael Selgas; M Auxiliadora Bajo; M J Fernandez-Reyes; E Bosque; K Lopez-Revuelta; C Jimenez; F Borrego; Fernando de Alvaro
An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kinetics.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1993;8(11):1244-53.
1993: Fernando de Alvaro; M J Castro; F Dapena; M Auxiliadora Bajo; M J Fernandez-Reyes; J R Romero; C Jimenez; Blanca Miranda; Rafael Selgas
Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1993;9():56-61.
1992: Fernando de Alvaro; M Auxiliadora Bajo; F Alvarez-Ude; Ana Vigil; A Molina; F Coronel; Rafael Selgas
Adequacy of peritoneal dialysis: does kt/v have the same predictive value as in HD? A multicenter study.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1992;8():93-7.
1992: Rafael Selgas; M J Castro; M Auxiliadora Bajo; M J Fernandez-Reyes; K Lopez-Revuelta; J R Romero; Fernando de Alvaro; F Borrego; C Riñon
Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu-erythropoietin?
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1992;8():253-7.
1992: Rafael Selgas; M V Cuesta; C Riñon; J R Romero; Fernando de Alvaro; M Auxiliadora Bajo; L Sanchez-Sicilia
Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-I (PAI-I) levels in plasma and peritoneal effluent in patients on CAPD.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1992;8():160-5.
1989: Rafael Selgas; J J Diez; J Muñoz; Blanca Miranda; Fernando de Alvaro; J C Rodriguez
Comparative study of two different routes for insulin administration in CAPD diabetic patients. A multicenter study.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 1989;5():181-4.